ClinicalTrials.gg

Vaxart clinical trials

What moves in its pipeline, every Monday. Free with an account during the beta.

The registry lists 29 studies whose lead sponsor is Vaxart or one of 3 companies grouped under it. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 9, 2026.

Our grouping of 4 registry names, not the registry’s. See them and correct one ↓

Pipeline: 4 programs

Each counted once: 4 with a study Vaxart leads registered in the last two years.

  • Phase 1
  • Phase 2

The 4 programs — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Vaxart’s own registered studies; Vaxart’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Vaxart’s studies test, most studies first; none is open now — 3 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Coming up

1 of Vaxart’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. 1M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

All 29 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Under way, not recruiting13%
  • Completed2690%
  • Stopped early27%Withdrawn 1 · Terminated 1

Phase

Where

  • United States24
  • Argentina2
  • Chile1
  • New Zealand1
  • Georgia1
  • Poland1

Over the years

  1. 11
  2. 12
  3. 13
  4. 14
  5. 15
  6. 516
  7. 17
  8. 18
  9. 19
  10. 20
  11. 21
  12. 22
  13. 23
  14. 24
  15. 25
  16. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Vaxart.

  • Vaxart
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    23 studies
  • Biota Pharmaceuticals, Inc.
    Acquired — became part of Vaxart, Feb 13, 2018 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • Aviragen Therapeutics
    Acquired — became part of Vaxart, Feb 13, 2018 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Anaconda Pharma
    Acquired — became part of Vaxart, Feb 13, 2018 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Studies

Recruiting first, then most recently updated. Showing 29 of 29.